Brasília – Hospitals dedicated exclusively to oncology care are losing attractiveness for investors in Brazil, according to Valor Econômico. Rising operating costs, shifts in treatment models, and changes in patient profiles have led to a preference for integrated hospital networks and outpatient cancer centers instead of large, standalone oncology units.

Industry experts note that the expansion of advanced outpatient therapies and home-based treatments has reduced the demand for inpatient cancer facilities. At the same time, the high cost of specialized infrastructure and uncertain reimbursement conditions have discouraged new projects in the sector.

Major hospital groups are now prioritizing diversified networks combining oncology services with other specialties, a trend that could reshape Brazil’s healthcare landscape. The move also reflects a global shift toward more decentralized, patient-centered cancer care models, with growing emphasis on early diagnosis and minimally invasive therapies.

Source: Valor Econômico

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com